AC Immune Ltd
Biotechnology
Healthcare
ACIU
101 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.56
52 week high
3.78
high
2.65
52 week low
0.00
low
2.51
growth
-31.71 %
previous Close
2.53
P/E ratio
market cap
215 M
div yield
0
usd
Jun 2025
qoq
revenue
1.31 M
31.92 %
net incoming
-21.19 M
-11.35 %
eps
0.00 %
-10.53 %
eps surprise
-20.55 %
net profit margin
-1622.43 %
299.00 %
operating incoming
-19.39 M
-0.09 %
net change in cash
8.04 M
149.27 %
cash on hand
25.72 M
28.87 %
cost of revenue
0.00 %
top top